BACKGROUND: The 2011 Dietary Reference Intakes (DRIs) for vitamin D use 25-hydroxyvitamin D [25(OH)D] concentrations to define vitamin D deficiency (<30 nmol/L), the Estimated Average Requirement (40 nmol/L), and the Recommended Dietary Allowance (RDA; 50 nmol/L). The Canadian population has not yet been assessed according to these recommendations. OBJECTIVE: We determined the prevalence of meeting DRI recommendations and the role of vitamin D supplement use among Canadians aged 6-79 y. DESIGN: Plasma 25(OH)D from a representative sample of Canadians in the Canadian Health Measures Survey-Cycle 1 (n = 5306) were used. Supplement use was assessed by household interview. Concentrations of 25(OH)D were compared in supplement users and nonusers by season and race. RESULTS: Overall, 5.4%, 12.7%, and 25.7% of the participants had 25(OH)D concentrations below the 30-, 40-, and 50-nmol/L cutoffs, respectively. In white Canadians, plasma 25(OH)D concentrations ranged from an undetectable percentage with concentrations <30 nmol/L in summer to 24.5% with concentrations <50 nmol/L in winter; the corresponding values ranged from 12.5% to 53.1% in nonwhite Canadians. Supplement users had significantly higher 25(OH)D concentrations than did nonusers, and no seasonal differences were found. In nonsupplement users, the prevalence of 25(OH)D concentrations <50 nmol/L in winter was 37.2% overall and was 60.7% in nonwhites. CONCLUSIONS: One-quarter of Canadians did not meet the RDA, but the use of vitamin D supplements contributed to a better 25(OH)D status. Nonwhite Canadians had the highest risk of not achieving DRI recommendations. More than one-third of Canadians not using supplements did not meet the RDA in winter. This suggests that current food choices alone are insufficient to maintain 25(OH)D concentrations of 50 nmol/L in many Canadians, especially in winter.
BACKGROUND: The 2011 Dietary Reference Intakes (DRIs) for vitamin D use 25-hydroxyvitamin D [25(OH)D] concentrations to define vitamin D deficiency (<30 nmol/L), the Estimated Average Requirement (40 nmol/L), and the Recommended Dietary Allowance (RDA; 50 nmol/L). The Canadian population has not yet been assessed according to these recommendations. OBJECTIVE: We determined the prevalence of meeting DRI recommendations and the role of vitamin D supplement use among Canadians aged 6-79 y. DESIGN: Plasma 25(OH)D from a representative sample of Canadians in the Canadian Health Measures Survey-Cycle 1 (n = 5306) were used. Supplement use was assessed by household interview. Concentrations of 25(OH)D were compared in supplement users and nonusers by season and race. RESULTS: Overall, 5.4%, 12.7%, and 25.7% of the participants had 25(OH)D concentrations below the 30-, 40-, and 50-nmol/L cutoffs, respectively. In white Canadians, plasma 25(OH)D concentrations ranged from an undetectable percentage with concentrations <30 nmol/L in summer to 24.5% with concentrations <50 nmol/L in winter; the corresponding values ranged from 12.5% to 53.1% in nonwhite Canadians. Supplement users had significantly higher 25(OH)D concentrations than did nonusers, and no seasonal differences were found. In nonsupplement users, the prevalence of 25(OH)D concentrations <50 nmol/L in winter was 37.2% overall and was 60.7% in nonwhites. CONCLUSIONS: One-quarter of Canadians did not meet the RDA, but the use of vitamin D supplements contributed to a better 25(OH)D status. Nonwhite Canadians had the highest risk of not achieving DRI recommendations. More than one-third of Canadians not using supplements did not meet the RDA in winter. This suggests that current food choices alone are insufficient to maintain 25(OH)D concentrations of 50 nmol/L in many Canadians, especially in winter.
Authors: Claudie Berger; Linda S Greene-Finestone; Lisa Langsetmo; Nancy Kreiger; Lawrence Joseph; Christopher S Kovacs; J Brent Richards; Nick Hidiroglou; Kurtis Sarafin; K Shawn Davison; Jonathan D Adachi; Jacques Brown; David A Hanley; Jerilynn C Prior; David Goltzman Journal: J Bone Miner Res Date: 2012-06 Impact factor: 6.741
Authors: Catherine Morgan; Linda Dodds; Donald B Langille; Hope A Weiler; B Anthony Armson; Jean-Claude Forest; Yves Giguère; Christy G Woolcott Journal: Arch Gynecol Obstet Date: 2015-09-24 Impact factor: 2.344
Authors: Kurtis Sarafin; Ramón Durazo-Arvizu; Lu Tian; Karen W Phinney; Susan Tai; Johanna E Camara; Joyce Merkel; Evan Green; Christopher T Sempos; Stephen P J Brooks Journal: Am J Clin Nutr Date: 2015-09-30 Impact factor: 7.045
Authors: Giuseppe Saggese; Francesco Vierucci; Annemieke M Boot; Justyna Czech-Kowalska; Giovanna Weber; Carlos A Camargo; Eric Mallet; Margherita Fanos; Nick J Shaw; Michael F Holick Journal: Eur J Pediatr Date: 2015-04-02 Impact factor: 3.183
Authors: Kevin D Cashman; Mairead Kiely; Michael Kinsella; Ramón A Durazo-Arvizu; Lu Tian; Yue Zhang; Alice Lucey; Albert Flynn; Michael J Gibney; Hubert W Vesper; Karen W Phinney; Paul M Coates; Mary F Picciano; Christopher T Sempos Journal: Am J Clin Nutr Date: 2013-04-24 Impact factor: 7.045
Authors: Christine Rake; Clare Gilham; Laurette Bukasa; Richard Ostler; Michelle Newton; James Peto Wild; Benoit Aigret; Michael Hill; Oliver Gillie; Irwin Nazareth; Peter Sasieni; Adrian Martineau; Julian Peto Journal: Health Technol Assess Date: 2020-02 Impact factor: 4.014
Authors: W Zhou; L Langsetmo; C Berger; S Poliquin; N Kreiger; S I Barr; S M Kaiser; R G Josse; J C Prior; T E Towheed; T Anastassiades; K S Davison; C S Kovacs; D A Hanley; E A Papadimitropoulos; D Goltzman Journal: J Musculoskelet Neuronal Interact Date: 2013-12 Impact factor: 2.041